Faron Pharmaceuticals - Company & Market Research Reports

Faron pharmaceuticals was founded in 2003 in Turku, Finland. It is a clinical stage drug discovery and development company. The company focuses on acute organ traumas, vascular damage, and cancer immunotherapy. Faron pharma is most well known for Traumakine, to prevent vascular leakage and organ failures, is currently the only treatment for Acute Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical trials. It also develops Clevegen, a preclinical immunotherapy candidate, designed to prevent tumor growth and metastasis that targets the tumor immune suppressor molecule.

Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Market Forecast - 2023 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Market Forecast - 2023

  • Drug Pipelines
  • 62 Pages
From
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2018 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2018

  • Report
  • 107 Pages
From
Acute Respiratory Distress Syndrome - Pipeline Insight, 2018 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Report
  • 2412 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018

  • Report
  • 498 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Report
  • 2011 Pages
From
Hodgkin Lymphoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Hodgkin Lymphoma - Pipeline Review, H1 2016

  • Report
  • 361 Pages
From
Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022 - Product Thumbnail Image

Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022

  • Drug Pipelines
  • 222 Pages
From
Clinical Research Organization (NORDIC) - Industry Report - Product Thumbnail Image

Clinical Research Organization (NORDIC) - Industry Report

  • Report
  • 160 Pages
From
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 110 Pages
From
African Trypanosomiasis - Pipeline Insight, 2018 - Product Thumbnail Image

African Trypanosomiasis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insight, 2018 - Product Thumbnail Image

Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insight, 2018

  • Drug Pipelines
  • 52 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Report
  • 1275 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H2 2017

  • Report
  • 1120 Pages
From
Liver Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H2 2016

  • Report
  • 1171 Pages
From
Brain Injury - Pipeline Review, H2 2015 - Product Thumbnail Image

Brain Injury - Pipeline Review, H2 2015

  • Report
  • 47 Pages
From
Competitor Analysis: Interferon - Product Thumbnail Image

Competitor Analysis: Interferon

  • Report
  • 89 Pages
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Report
  • 1103 Pages
From
Faron Pharmaceuticals Oy (FARN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Faron Pharmaceuticals Oy (FARN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Loading Indicator
adroll